Reply to Anirban P. Mitra, Tanner Miest, and Colin P.N. Dinney's words of wisdom re: genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer. Eur Urol 2021;79:428-9

Perera Bel, JúliaBellmunt Molins, Joaquim, 1959-2021-06-252021Perera-Bel J, Bellmunt J. Reply to Anirban P. Mitra, Tanner Miest, and Colin P.N. Dinney's words of wisdom re: genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer. Eur Urol 2021;79:428-9. Eur Urol 2021; 79: 428-9. Eur Urol. 2021 Apr; 79(4): e119-20. DOI: 10.1016/j.eururo.2020.12.0380302-2838http://hdl.handle.net/10230/47977application/pdfeng© Elsevier http://dx.doi.org/10.1016/j.eururo.2020.12.038Reply to Anirban P. Mitra, Tanner Miest, and Colin P.N. Dinney's words of wisdom re: genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer. Eur Urol 2021;79:428-9info:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.eururo.2020.12.038Bufeta -- Càncer -- GenèticaBufeta -- Malaltiesinfo:eu-repo/semantics/openAccess